Stoltmann Law Offices is investigating potential claims on behalf of investors who may have invested in purchases of the securities of Neovasc Inc., during the period between January 26, 2015 and May 19th, 2016. On May 19th, 2016, news sources reported that a Massachusetts federal jury had reached a judgment and awarded $70 million to Neovasc’s rival company, CardiAQ Valve Technologies Inc. (CardiAQ). A jury found that Neovasc had stolen trade secrets from CardiAQ Valve Technologies Inc. Please contact our Chicago-based law offices if you invested with Neovasc Inc. We are securities attorneys who may be able to help you recover your investment losses in the Financial Industry Regulatory Authority (FINRA) arbitration forum on a contingency fee basis. The call is free with no obligation. Please call today. 312-332-4200.
Disclaimer
The posting on this site are mere OPINIONS and NOT statements of fact in any way whatsoever. The information should not be relied upon and there have been no findings made against the firms or individuals referenced on this site. In addition, this Blog is made available for educational purposes only and incorporates information from the web as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this blog site you understand that there is no attorney client relationship between you and Stoltmann Law Offices (161 N Clark Street 16th Floor Chicago, IL 60601). The Blog opinions should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.
PLEASE NOTE THIS IS ADVERTISING AND IT IS NOT A NEWSPAPER ARTICLE OR POST FROM AN INDEPENDENT OR NON-BIASED, NEWS SITE, NEWS SOURCE OR NEWSPAPER.
